Market Overview:
The global anaplastic thyroid cancer therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of anaplastic thyroid cancer, rising awareness about available treatment options, and growing demand for novel therapies. The global anaplastic thyroid cancer therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into oral and injection therapies. Oral therapies are further sub-segmented into small molecule inhibitors and monoclonal antibodies. Injection therapies are further sub-segmented into tyrosine kinase inhibitors (TKIs) and other injectable drugs. On the basis of application, the market is segmented into hospital pharmacies, retail pharmacies/drug stores, and other applications such as research institutes & contract research organizations (CROs). The hospital pharmacy segment accounted for a major share of the global anaplastic thyroid cancer therapeutics market in 2017 owing to increased use of targeted therapy drugs in hospitals compared with retail pharmacies/drug stores.
Product Definition:
The term anaplastic thyroid cancer therapeutics refers to the use of drugs, radiation therapy, and surgery to treat anaplastic thyroid cancer. The importance of anaplastic thyroid cancer therapeutics lies in the fact that this type of cancer is very aggressive and can be difficult to treat.
Oral:
Oral is a form of therapy which helps in the administration of drugs to patients by mouth. The most common types of oral therapies are chemotherapy, hormone therapy, and radiation therapy. Chemotherapy is the most common type used for cancer treatment and includes drug delivery through mouth by parenteral route or oral route.
Injection:
Injection is a drug delivery system that involves the administration of drugs into the bloodstream or muscle tissues. In cancer treatment, injections are used to deliver cytotoxic drugs and radioactive materials which help in targeting cancer cells. The most common types of cancers treated with injections include thyroid carcinoma, breast carcinoma, lung carcinoma and skin melanomas.
Application Insights:
Drugstore was the dominant application segment in 2017. The growth of this segment can be attributed to increasing awareness about the benefits of early diagnosis and treatment, which is driving Anaplastic Thyroid Cancer (ATC) drugs store sales. In addition, hospital-based therapies are considered as primary treatment option for patients with metastatic disease who cannot undergo surgery or cannot have it due to other pre-existing health conditions. Hence, hospital dominated the market in 2017 and is expected to continue leading over the forecast period owing to its high usage rate across various regions coupled with rising awareness about ATC therapeutics among healthcare professionals.
The oral therapy segment held a significant share in global anaplastic thyroid cancer therapeutics market owing to growing R&D initiatives by several companies including Merck Millipore Corporation; Pfizer;.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased R&D activities, and high adoption of modern treatment procedures. In addition, favorable reimbursement policies for patients are also expected to drive growth during the forecast period. Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing disposable income levels and rising awareness about early diagnosis in emerging countries such as China & India. Moreover, government initiatives encouraging individuals from all economic backgrounds are likely to contribute towards this growth as well (for instance “One-Two-Three†initiative by Chinese Government).
Moreover, growing medical tourism industry due to low cost of treatment is further anticipated boost revenue generation capacity within this region during same period.
Growth Factors:
- Increasing incidence of anaplastic thyroid cancer
- Growing awareness about anaplastic thyroid cancer and its treatment options
- Rising demand for better and more effective therapies for anaplastic thyroid cancer
- Availability of government funding for research on anaplastic thyroid cancer therapies
- Technological advancements in the field of anaplastic thyroid cancer therapeutics
Scope Of The Report
Report Attributes
Report Details
Report Title
Anaplastic Thyroid Cancer Therapeutics Market Research Report
By Type
Oral, Injection
By Application
Hospital, Drugs Store, Other
By Companies
Novartis, Sanofi Genzyme
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
163
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Anaplastic Thyroid Cancer Therapeutics Market Report Segments:
The global Anaplastic Thyroid Cancer Therapeutics market is segmented on the basis of:
Types
Oral, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Sanofi Genzyme
Highlights of The Anaplastic Thyroid Cancer Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injection
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anaplastic Thyroid Cancer Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anaplastic thyroid cancer therapies are medications that aim to stop or slow the growth of cancer cells in the thyroid gland.
Some of the major players in the anaplastic thyroid cancer therapeutics market are Novartis, Sanofi Genzyme.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anaplastic Thyroid Cancer Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anaplastic Thyroid Cancer Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anaplastic Thyroid Cancer Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anaplastic Thyroid Cancer Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anaplastic Thyroid Cancer Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Anaplastic Thyroid Cancer Therapeutics Market Size and Y-o-Y Growth
4.5.2 Anaplastic Thyroid Cancer Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Anaplastic Thyroid Cancer Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anaplastic Thyroid Cancer Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anaplastic Thyroid Cancer Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anaplastic Thyroid Cancer Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Type
9.6.1 Oral
9.6.2 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anaplastic Thyroid Cancer Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Type
10.6.1 Oral
10.6.2 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anaplastic Thyroid Cancer Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Type
11.6.1 Oral
11.6.2 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anaplastic Thyroid Cancer Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Type
12.6.1 Oral
12.6.2 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anaplastic Thyroid Cancer Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Type
13.6.1 Oral
13.6.2 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anaplastic Thyroid Cancer Therapeutics Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anaplastic Thyroid Cancer Therapeutics Market: Competitive Dashboard
14.2 Global Anaplastic Thyroid Cancer Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Sanofi Genzyme
